Bacterial vaginosis (BV) is a leading cause of symptomatic vaginitis in North American populations. BV is also associated with adverse reproductive health outcomes such as miscarriage, preterm birth, and increased risk for sexually transmitted diseases. Treatment of this common disorder is mostly effective in the short term, but recurrence is common. Current treatment guidelines will be reviewed, as well as alternative regimens and treatments, some of which may not be FDA-approved for treating BV. This presentation will discuss the short and long term efficacy of recommended antibiotic treatment regimens, as well as alternative treatment and prevention strategies such as boric acid and probiotics. The role of treatment for prevention of adverse health outcomes will be reviewed. Predictors of treatment success will be discussed, and incorporated into practical advice for patients and treating providers.

Disclosure No significant relationships.